Comprehensive Analysis of Diagnostic Imaging Collaboration and Licensing Deals (2016-2023)

DUBLIN, Jan. 11, 2024 /PRNewswire/ — The “Diagnostic Imaging Collaboration and Licensing Deals 2016-2023” report has been added to’s offering.

The report on diagnostic imaging collaboration and licensing deals has been made accessible, offering extensive insight into the biopharma industry’s activities in this critical sector from 2016 to 2023. This report provides an unprecedented level of detail and analysis of diagnostic imaging deals, offering stakeholders a significant information advantage in their strategic planning and business development efforts.

Industry Analytics Reveal Key Trends and Strategic Dealings

  • The report offers a detailed look at the trends impacting diagnostic imaging deal-making since 2016, enhancing the understanding of sector dynamics.
  • An overview of the financials – including upfront, milestone, and royalty payments – enables companies to benchmark transaction values effectively.
  • Analytical perspectives on the 567 documented diagnostic imaging deals lend essential context to the market’s direction and momentum.
  • It provides an insightful directory of deals categorized by company, deal type, and therapeutic focus for easy reference and targeted research.

An invaluable resource for industry professionals, the report delves into the specifics of multicomponent deals, including collaborative R&D, as well as the subsequent commercialization strategies. It also covers a wide range of arrangements from pure licensing deals to comprehensive research and development collaborations, providing a clear understanding of the structures and terms prevalent within the diagnostic imaging marketplace.

Top Deals and Active Dealmakers

Insight into the top 25 most active companies in diagnostic imaging deal-making forms a core component of the report, shedding light on the major players shaping the landscape. Noteworthy deals by value are highlighted, featuring comprehensive listings including not only the deal terms but also where available, public contracts, and supporting documentation.

Strategic Benefits and In-Depth Deal Analysis

With a focus on 2016 onward, the report delivers a critical deep-dive into the contractual aspects of diagnostic imaging deals. Professionals within the biopharma sector stand to gain a robust understanding of deal structures, rights granted, exclusivity terms, and much more. By analyzing deal contracts, the report facilitates thorough due diligence, enabling companies to navigate the complexity of licensing agreements confidently.

The robust directory and accessible weblinks to contract documents offer immediate resources for further exploration of specific deals, while a multitude of tables and figures provide visual representations of trends and activities in the diagnostic imaging arena since 2016.

Overall, the report represents an essential tool for anyone involved or interested in the diagnostic imaging sector. It provides comprehensive access to data and analyses that support informed decision making, strategic planning, and the identification of new opportunities within the field of diagnostic imaging.

This compilation of data and expert analysis on past and present deals offers strategic insights that benefit a broad range of stakeholders in the biopharma and diagnostic imaging industries. It is a rich resource for those looking to understand the intricacies and future direction of collaboration and licensing in the diagnostic imaging space.

Sourcing the right partners, understanding the competitive landscape, and gauging the financial and strategic value of deals have never been more crucial. This report gives stakeholders the analytical advantage required to thrive in the dynamic world of diagnostic imaging.

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


SOURCE Research and Markets

Originally published at
Images courtesy of